Sun Pharma Advanced Research Company Limited (NSE:SPARC)

India · Delayed Price · Currency is INR

206.50

-1.93 (-0.93%)

Jul 31, 2026, 3:30 PM IST

NSE:SPARC Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	18,792	18,792	717.66	755.45	2,388	1,372
Revenue Growth	2518.47%	2518.47%	-5.00%	-68.36%	73.98%	-45.74%
Gross Profit	18,492	18,492	415.66	391.07	2,105	1,137
Operating Income	15,989	15,989	-3,341	-4,115	-2,236	-1,961
Net Income	15,532	15,532	-3,425	-3,872	-2,226	-2,034
Earnings Per Share	47.86	47.86	-10.55	-11.93	-7.82	-7.73
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	380.49	380.49	700.82	749.01	1,071	1,322
Outside India	11	11	16.84	6.44	1,317	50.21
Total	391.48	391.48	717.66	755.45	2,388	1,372

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	11.55	11.55	19.64	1,571	4,025	128.89
Total Debt	5,593	5,593	2,689	611.51	156.75	792.14
Net Cash (Debt)	-5,582	-5,582	-2,670	959.8	3,868	-663.25
Net Cash Growth	-	-	-	-75.19%	-	-
Net Cash Per Share	-17.20	-17.20	-8.23	2.96	13.59	-2.52

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-2,388	-2,388	-3,603	-4,292	-691.18	-2,082
Capital Expenditures	-238.31	-238.31	-103.4	-265.08	-153.87	-326.78
Free Cash Flow	-2,626	-2,626	-3,706	-4,557	-845.05	-2,409
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	98.41%	98.41%	57.92%	51.77%	88.14%	82.83%
Operating Margin	85.09%	85.09%	-465.49%	-544.71%	-93.66%	-142.86%
Pretax Margin	82.64%	82.64%	-477.64%	-512.05%	-93.22%	-148.19%
Profit Margin	82.65%	82.65%	-477.26%	-512.56%	-93.22%	-148.20%
FCF Margin	-13.98%	-13.98%	-516.45%	-603.21%	-35.39%	-175.53%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	4.31	2.40	-	-	-	-
Forward PE	-	91.22	91.22	91.22	91.22	91.22
PS Ratio	3.56	1.98	66.88	158.21	24.38	58.82